Part 3 of the Dow review MSFT Forecast: "..$62.14 Microsoft was one of the steadiest performers of the Dow in 2016 with price action consistently showing a higher relative strength than the S&P. Despite the steady advance all year, the SCTR still remains high at 78 and looks very strong. The PNF chart shows a … Continue reading That Was Then, This Is Now Part 3
PFE
Pharma ABBV
While not appearing in headlines every day in the financial press, big pharmaceutical and healthcare stocks have been advancing, if unevenly along with the general buoyancy of the overall markets. The chart of Eli Lilly shown below is an example of the building bullish patterns on many of the classic big pharma stocks including Merck, … Continue reading Pharma ABBV
TC-TECHNICALS 